Inhaled Nitric Oxide Market Size to Soar at Steady CAGR to 2023 Led by North America and Europe

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Request a Sample Copy: https://www.researchbeam.com/global-inhaled-nitric-oxide-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=OPR&utm_medium=CC

This report focuses on the Inhaled Nitric Oxide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.

According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.

Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.

The worldwide market for Inhaled Nitric Oxide is expected to grow at a CAGR of roughly 7.9% over the next five years, will reach 1240 million US$ in 2023, from 780 million US$ in 2017, according to a new study.

Get a Discount on this research report: https://www.researchbeam.com/global-inhaled-nitric-oxide-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/purchase-enquiry?utm_source=OPR&utm_medium=CC

Market Segment by Manufacturers, this report covers Mallinckrodt, Praxair, Air Liquide and more. Also, the global market segment by regions, regional analysis covers North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

The global Inhaled Nitric Oxide Market Segment by Type, covers 99.92% Purity, 99.99% Purity and other. Also the industry segment by applications, can be divided into ARDS, PPHN and other diseases.

Related Report:

Global Nitric Oxide Therapy System Market Professional Survey Report 2018

This report studies Nitric Oxide Therapy System in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering International Biomedical, SLE, EKU Elektronik GmbH, BOC Healthcare, INOpulse, Dan Hammer Health LTD and Praxair.

Read More: https://www.researchbeam.com/global-nitric-oxide-therapy-system-professional-survey-report-2018-market?utm_source=RR-OPR&utm_medium=CC

About Us:

Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.

We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.